These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12679744)

  • 1. Psychopharmacologic strategies for the treatment of aggression in juveniles.
    Steiner H; Saxena K; Chang K
    CNS Spectr; 2003 Apr; 8(4):298-308. PubMed ID: 12679744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
    Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
    J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
    Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
    Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of aggression in children and adolescents with autism and conduct disorder.
    McDougle CJ; Stigler KA; Posey DJ
    J Clin Psychiatry; 2003; 64 Suppl 4():16-25. PubMed ID: 12672261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management.
    Scotto Rosato N; Correll CU; Pappadopulos E; Chait A; Crystal S; Jensen PS;
    Pediatrics; 2012 Jun; 129(6):e1577-86. PubMed ID: 22641763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication strategies in childhood aggression: a review.
    Bassarath L
    Can J Psychiatry; 2003 Jul; 48(6):367-73. PubMed ID: 12894610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aggressive and violent behavior in adolescents].
    Reneric JP; Bouvard MP
    Encephale; 2009 Jun; 35 Suppl 4():S127-8. PubMed ID: 19559826
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    Weller EB; Rowan A; Elia J; Weller RA
    J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacologic management of aggression.
    Newman WJ
    Psychiatr Clin North Am; 2012 Dec; 35(4):957-72. PubMed ID: 23107573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder.
    Greene RW; Biederman J; Zerwas S; Monuteaux MC; Goring JC; Faraone SV
    Am J Psychiatry; 2002 Jul; 159(7):1214-24. PubMed ID: 12091202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experts' recommendations for treating maladaptive aggression in youth.
    Pappadopulos E; Rosato NS; Correll CU; Findling RL; Lucas J; Crystal S; Jensen PS
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):505-15. PubMed ID: 22196314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of Aggression in Child and Adolescent Psychiatric Disorders.
    Gurnani T; Ivanov I; Newcorn JH
    J Child Adolesc Psychopharmacol; 2016 Feb; 26(1):65-73. PubMed ID: 26881859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological management of aggression and violence.
    Humble F; Berk M
    Hum Psychopharmacol; 2003 Aug; 18(6):423-36. PubMed ID: 12923820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of comorbidity in conduct disorder with attention-deficit hyperactivity disorder (ADHD).
    Turgay A
    Essent Psychopharmacol; 2005; 6(5):277-90. PubMed ID: 16222912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological aspects of the treatment of conduct disorder in children and adolescents.
    Tcheremissine OV; Lieving LM
    CNS Drugs; 2006; 20(7):549-65. PubMed ID: 16800715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggression and disruptive behavior disorders in children and adolescents.
    Turgay A
    Expert Rev Neurother; 2004 Jul; 4(4):623-32. PubMed ID: 15853581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.